Moscow has formally acknowledged its military's role in helping Nigerien forces thwart a coordinated ISIL attack on Niamey's main airport last week, an incident that left 20 assailants dead and underscores Russia's deepening security footprint in the Sahel.
Even as Berkshire Hathaway enters a new chapter, the enduring value of Warren Buffett's investment philosophy shines through in two financial sector holdings—Ally Financial and Jefferies Financial—that analysts see as compelling opportunities this February.
Market analysts have significantly raised their revenue and earnings forecasts for Impala Platinum Holdings, projecting a sharp recovery and growth rate that outpaces the broader mining sector.
Blue Bird Corporation (BLBD) is poised to release its latest quarterly results after Wednesday's market close. Investors will be watching to see if the manufacturer can maintain its pattern of outperforming Wall Street's forecasts amidst a mixed landscape for heavy equipment peers.
As PTC prepares to release its Q4 financial results, investors are weighing its strong historical performance against a turbulent market for vertical software stocks. Here’s the breakdown.
Nomura Holdings announces a significant share buyback program while tightening risk controls at its digital asset unit, Laser Digital. The move signals a dual focus on immediate capital returns and long-term, regulated growth in the crypto space, as the financial giant navigates a volatile market.
Arcellx shares have delivered stellar multi-year gains, prompting investors to question if the rally still has room to run. A deep dive into valuation metrics reveals a complex picture, with discounted cash flow models pointing to significant upside while price-to-book ratios suggest a more cautious stance.
Eli Lilly's $3.5 billion investment in a new Pennsylvania facility for injectable weight-loss drugs, including retatrutide, spotlights its aggressive expansion in the obesity market. This strategic move, coupled with strong analyst sentiment and upcoming earnings, intensifies focus on the company's growth trajectory and premium valuation.
Shares of Coastal Financial (CCB) have tumbled over 13% in the past month, sparking debate among investors. While a proprietary valuation model suggests the stock is deeply undervalued, its premium P/E ratio tells a conflicting story. We examine the numbers and the broader context for regional banks.
U.S. immigration authorities will not conduct enforcement actions at this Sunday's Super Bowl, sources tell Reuters, as the event becomes a flashpoint in the nation's heated immigration debate.
Kemper Corporation is set to report its fourth-quarter earnings Wednesday afternoon, with investors watching closely for signs of stability after a period of mixed performance and sector-wide pressure.
Matrix Service Company (MTRX) is set to release its fourth-quarter financial results after the market closes Wednesday. Investors will be watching to see if the industrial construction firm can meet elevated revenue forecasts and translate top-line growth into stronger profitability.
OpenText's appointment of former IBM Americas President Ayman Antoun as its new CEO, effective April 2026, has been met with a sharp sell-off. While the move brings deep cloud and AI expertise, investors appear wary of the leadership transition and strategic pivot amid ongoing portfolio restructuring and debt concerns.
All eyes are on Corpay (NYSE: CPAY) as the business payments firm prepares to release its quarterly results after Wednesday's closing bell. Analysts project robust revenue growth, but a history of misses adds intrigue to the report.
Alphabet's self-driving unit Waymo has raised $16 billion in a landmark funding round, valuing the company at $126 billion. The capital injection, backed by major investors including Alphabet and Dragoneer, is set to fuel an aggressive international expansion of its autonomous ride-hailing service.
As Evercore prepares to report fourth-quarter results, analysts anticipate steady revenue growth. The firm's consistent history of beating estimates and the performance of its peers set the stage for a closely watched announcement.
All eyes are on healthcare giant McKesson as it prepares to report fourth-quarter results. With a history of revenue misses and a slowing growth rate, analysts and investors are keen to see if the company can deliver a positive surprise.
Globe Life (NYSE: GL) is set to report its fourth-quarter earnings after the market closes on Wednesday. With the insurance sector facing headwinds, investors are watching to see if the company can deliver growth that outpaces its recent history of revenue misses.
CDW Corporation is set to report its fourth-quarter earnings before the market opens on Wednesday. Analysts project modest revenue growth, but the company's recent performance and broader sector trends suggest a cautious outlook.
New late-breaking data for Nektar Therapeutics' lead drug candidate, rezpegaldesleukin, suggests systemic anti-inflammatory benefits in patients with comorbid asthma, potentially expanding its market reach and strengthening the investment case for the biopharma firm.
